posted by user: ISSAD || 897 views || tracked by 1 users: [display]

ISSAD 2021 : The 2nd International Symposium on ‘Streptococcus agalactiae’ Disease

FacebookTwitterLinkedInGoogle

Link: http://www.issad.org
 
When Nov 3, 2021 - Nov 5, 2021
Where London
Submission Deadline Jul 12, 2021
Notification Due Aug 3, 2021
Final Version Due Oct 1, 2021
Categories    group b strep   meningitis   pregnancy   women's health
 

Call For Papers

ISSAD Scientific Committee invites delegates to submit abstracts for oral or poster presentation at ISSAD-2021. Please note that all travel scholarships will be determined competitively based on abstracts. Note that travel may not be possible depending on COVID-19 restrictions.

Once reviewed by the International Scientific Committee (ISC), feedback will be given on the acceptance of abstracts by Tuesday 3rd August 2021. Presentations of original data not yet published or presented elsewhere, prior to ISSAD 2021 is highly recommended. We will also consider abstracts related to 2020 publications, contingent on compliance with applicable copyright laws with publishing journal. Authors are responsible for ensuring that there is no infringement of copyright.

Please specify which of the 8 tracks you wish to be considered for. You may indicate more than one track.

Abstracts Open Monday 17th May 2021, 9.00 am BST

Abstracts Close Monday 12th July 2021, 12.00 am-midnight BST

Abstract Decision confirmation on Tuesday 3rd August 2021

Abstract Tracks:

1. Epidemiology and burden

2. Micro and molecular

3. Immunity and sero epi

4. Vaccines

5. Implementation, integration, M&E

6. Parent and societal

7. Economics

8. Hot Topics

You may also indicate your preference for oral or poster, but fewer orals will be selected so you may be offered the opportunity for a poster instead.

For more information, please contact Mita Vaghji at issad@lshtm.ac.uk.

Abstract guidelines:

*A Microsoft Word abstract template is available on the ISSAD Website. Please use this template for abstract preparation.

*Abstract title (limited to 30 words)

*Authors: Presenting author’s contact details (full first and family name, identification number, affiliation details, e-mail) Add co-authors (full first and family name, affiliation details, e-mail)

*Abstract text: limited to 300 words (please check the word count using word processing software); presented in clear English. Use sub-sections for your abstract text: introduction, methods, results, conclusion

*All abbreviations and acronyms must be defined on first use. Use generic names of drugs

*One table or one graph can be added per abstract. Such table or graph counts for 50 words

*Abstracts may be selected for oral presentation (15 minutes talk including questions), “elevator talk” (3 minutes talk with no follow-up question) or poster. Please indicate if you prefer one or several of these formats at the time of submission

*Please select whether you consider yourself as ‘Young ISSAD’. ‘Young ISSAD’ is determined as any early career stage prior to tenured professor or equivalent.

Related Resources

EAIH 2024   Explainable AI for Health
DLAADR 2024   Deep Learning for Advancing Alzheimer's Disease Research
METABOLISM 2024   Exploring the Links Between Obesity and its Adverse Health Outcomes